Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 89

1.

Performance of GFR Slope as a Surrogate Endpoint for Kidney Disease Progression in Clinical Trials: A Statistical Simulation.

Greene T, Ying J, Vonesh EF, Tighiouart H, Levey AS, Coresh J, Herrick JS, Imai E, Jafar TH, Maes BD, Perrone RD, Del Vecchio L, Wetzels JFM, Heerspink HJL, Inker LA.

J Am Soc Nephrol. 2019 Jul 10. pii: ASN.2019010009. doi: 10.1681/ASN.2019010009. [Epub ahead of print]

PMID:
31292198
2.

GFR Slope as a Surrogate End Point for Kidney Disease Progression in Clinical Trials: A Meta-Analysis of Treatment Effects of Randomized Controlled Trials.

Inker LA, Heerspink HJL, Tighiouart H, Levey AS, Coresh J, Gansevoort RT, Simon AL, Ying J, Beck GJ, Wanner C, Floege J, Li PK, Perkovic V, Vonesh EF, Greene T.

J Am Soc Nephrol. 2019 Jul 10. pii: ASN.2019010007. doi: 10.1681/ASN.2019010007. [Epub ahead of print]

PMID:
31292197
3.

Association between cumulative anticholinergic burden and falls and fractures in patients with overactive bladder: US-based retrospective cohort study.

Szabo SM, Gooch K, Schermer C, Walker D, Lozano-Ortega G, Rogula B, Deighton A, Vonesh E, Campbell N.

BMJ Open. 2019 May 5;9(5):e026391. doi: 10.1136/bmjopen-2018-026391.

4.

Cardiovascular risk profile in individuals initiating treatment for overactive bladder - Challenges and learnings for comparative analysis using linked claims and electronic medical record databases.

Vonesh E, Gooch KL, Khangulov V, Schermer CR, Johnston KM, Szabo SM, Rumsfeld JS.

PLoS One. 2018 Oct 16;13(10):e0205640. doi: 10.1371/journal.pone.0205640. eCollection 2018.

5.

Calculating Standard Kt/V during Hemodialysis Based on Urea Mass Removed.

Leypoldt JK, Vonesh EF.

Blood Purif. 2019;47(1-3):62-68. doi: 10.1159/000493178. Epub 2018 Oct 8.

PMID:
30296780
6.

The authors reply.

Kumar VA, Sidell MA, Jones JP, Vonesh EF.

Kidney Int. 2015 Jun;87(6):1260. doi: 10.1038/ki.2015.55. No abstract available.

PMID:
26024034
7.

Survival of propensity matched incident peritoneal and hemodialysis patients in a United States health care system.

Kumar VA, Sidell MA, Jones JP, Vonesh EF.

Kidney Int. 2014 Nov;86(5):1016-22. doi: 10.1038/ki.2014.224. Epub 2014 Jul 2.

8.

PSA enzymatic activity: a new biomarker for assessing prostate cancer aggressiveness.

Ahrens MJ, Bertin PA, Vonesh EF, Meade TJ, Catalona WJ, Georganopoulou D.

Prostate. 2013 Dec;73(16):1731-7. doi: 10.1002/pros.22714. Epub 2013 Aug 9.

PMID:
23934862
9.

Survival advantage of icodextrin peritoneal dialysis solution in a time-dependent model.

Ahn SV, Vonesh E, Han SH.

Am J Kidney Dis. 2013 Feb;61(2):351-2. doi: 10.1053/j.ajkd.2012.10.007. Epub 2012 Nov 14. No abstract available.

PMID:
23157934
10.

Hemodialysis and peritoneal dialysis are associated with similar outcomes for end-stage renal disease treatment in Canada.

Yeates K, Zhu N, Vonesh E, Trpeski L, Blake P, Fenton S.

Nephrol Dial Transplant. 2012 Sep;27(9):3568-75. doi: 10.1093/ndt/gfr674. Epub 2012 Mar 5.

PMID:
22391139
11.

Hemodialysis vascular access modifies the association between dialysis modality and survival.

Perl J, Wald R, McFarlane P, Bargman JM, Vonesh E, Na Y, Jassal SV, Moist L.

J Am Soc Nephrol. 2011 Jun;22(6):1113-21. doi: 10.1681/ASN.2010111155. Epub 2011 Apr 21.

12.

Changes in free water fraction and aquaporin function with dwell time during continuous ambulatory peritoneal dialysis.

Stachowska-Pietka J, Waniewski J, Vonesh E, Lindholm B.

Artif Organs. 2010 Dec;34(12):1138-43.

PMID:
21192338
13.

What is the true number needed to screen and treat to save a life with prostate-specific antigen testing?

Loeb S, Vonesh EF, Metter EJ, Carter HB, Gann PH, Catalona WJ.

J Clin Oncol. 2011 Feb 1;29(4):464-7. doi: 10.1200/JCO.2010.30.6373. Epub 2010 Dec 28.

14.

Assessing creatinine clearance from modification of diet in renal disease study equations in the ADEMEX cohort: limitations and potential applications.

Sloand JA, Leypoldt JK, Culleton BF, Gellens ME, Paniagua R, Amato D, Vonesh EF.

Clin J Am Soc Nephrol. 2011 Mar;6(3):598-604. doi: 10.2215/CJN.04970610. Epub 2010 Dec 16.

15.

Similar outcomes with hemodialysis and peritoneal dialysis in patients with end-stage renal disease.

Mehrotra R, Chiu YW, Kalantar-Zadeh K, Bargman J, Vonesh E.

Arch Intern Med. 2011 Jan 24;171(2):110-8. doi: 10.1001/archinternmed.2010.352. Epub 2010 Sep 27.

PMID:
20876398
16.

Risk factors for prostate cancer detection after a negative biopsy: a novel multivariable longitudinal approach.

Gann PH, Fought A, Deaton R, Catalona WJ, Vonesh E.

J Clin Oncol. 2010 Apr 1;28(10):1714-20. doi: 10.1200/JCO.2008.20.3422. Epub 2010 Feb 22.

17.
18.

The outcomes of continuous ambulatory and automated peritoneal dialysis are similar.

Mehrotra R, Chiu YW, Kalantar-Zadeh K, Vonesh E.

Kidney Int. 2009 Jul;76(1):97-107. doi: 10.1038/ki.2009.94. Epub 2009 Apr 1.

19.

Icodextrin does not impact infectious and culture-negative peritonitis rates in peritoneal dialysis patients: a 2-year multicentre, comparative, prospective cohort study.

Vychytil A, Remón C, Michel C, Williams P, Rodríguez-Carmona A, Marrón B, Vonesh E, van der Heyden S, Divino Filho JC; Extraneal Peritonitis Study Group.

Nephrol Dial Transplant. 2008 Nov;23(11):3711-9. doi: 10.1093/ndt/gfn322. Epub 2008 Jun 13.

20.

Predictive value of brain natriuretic peptides in patients on peritoneal dialysis: results from the ADEMEX trial.

Paniagua R, Amato D, Mujais S, Vonesh E, Ramos A, Correa-Rotter R, Horl WH.

Clin J Am Soc Nephrol. 2008 Mar;3(2):407-15. doi: 10.2215/CJN.03820907. Epub 2008 Jan 16.

21.

Dialysis or not? A comparative survival study of patients over 75 years of age with chronic kidney disease stage 5.

Misra M, Oreopoulos D, Vonesh E.

Nephrol Dial Transplant. 2008 May;23(5):1768-9; author reply 1769. Epub 2007 Dec 17. No abstract available.

PMID:
18086822
22.

Why is the evidence favoring hemodialysis over peritoneal dialysis misleading?

Burkart J, Piraino B, Kaldas H, Lee JY, Bender FH, Krediet RT, Boeschoten EW, Dekker FW, Vonesh E, Mujais S.

Semin Dial. 2007 May-Jun;20(3):200-2. Review. No abstract available.

PMID:
17555481
23.

ADEMEX: the evidence and the nephrosopher.

Mujais S, Vonesh E.

Perit Dial Int. 2007 May-Jun;27(3):234-7. No abstract available.

PMID:
17468467
24.

Effects of radiotherapy with or without chemotherapy on tongue strength and swallowing in patients with oral cancer.

Lazarus C, Logemann JA, Pauloski BR, Rademaker AW, Helenowski IB, Vonesh EF, Maccracken E, Mittal BB, Vokes EE, Haraf DJ.

Head Neck. 2007 Jul;29(7):632-7.

PMID:
17230558
25.

Mortality studies comparing peritoneal dialysis and hemodialysis: what do they tell us?

Vonesh EF, Snyder JJ, Foley RN, Collins AJ.

Kidney Int Suppl. 2006 Nov;(103):S3-11. Review.

26.

The reverse epidemiology of plasma total homocysteine as a mortality risk factor is related to the impact of wasting and inflammation.

Suliman M, Stenvinkel P, Qureshi AR, Kalantar-Zadeh K, Bárány P, Heimbürger O, Vonesh EF, Lindholm B.

Nephrol Dial Transplant. 2007 Jan;22(1):209-17. Epub 2006 Sep 17.

PMID:
16982634
27.

Modeling of icodextrin in PD Adequest 2.0.

Vonesh EF, Story KO, Douma CE, Krediet RT.

Perit Dial Int. 2006 Jul-Aug;26(4):475-81.

PMID:
16881343
28.

Estrogen and progesterone levels in nipple aspirate fluid of healthy premenopausal women: relationship to steroid precursors and response proteins.

Gann PH, Geiger AS, Helenowski IB, Vonesh EF, Chatterton RT.

Cancer Epidemiol Biomarkers Prev. 2006 Jan;15(1):39-44.

29.

D-dimer and inflammatory markers as predictors of functional decline in men and women with and without peripheral arterial disease.

McDermott MM, Ferrucci L, Liu K, Criqui MH, Greenland P, Green D, Guralnik JM, Ridker PM, Taylor LM, Rifai N, Tian L, Zheng J, Pearce WH, Schneider JR, Vonesh E.

J Am Geriatr Soc. 2005 Oct;53(10):1688-96.

PMID:
16181167
30.

Shared parameter models for the joint analysis of longitudinal data and event times.

Vonesh EF, Greene T, Schluchter MD.

Stat Med. 2006 Jan 15;25(1):143-63.

PMID:
16025541
31.

Patient education and access of ESRD patients to renal replacement therapies beyond in-center hemodialysis.

Mehrotra R, Marsh D, Vonesh E, Peters V, Nissenson A.

Kidney Int. 2005 Jul;68(1):378-90.

32.

Health-related quality of life predicts outcomes but is not affected by peritoneal clearance: The ADEMEX trial.

Paniagua R, Amato D, Vonesh E, Guo A, Mujais S; Mexican Nephrology Collaborative Study Group.

Kidney Int. 2005 Mar;67(3):1093-104.

33.

The differential impact of risk factors on mortality in hemodialysis and peritoneal dialysis.

Vonesh EF, Snyder JJ, Foley RN, Collins AJ.

Kidney Int. 2004 Dec;66(6):2389-401.

34.

Functional decline in peripheral arterial disease: associations with the ankle brachial index and leg symptoms.

McDermott MM, Liu K, Greenland P, Guralnik JM, Criqui MH, Chan C, Pearce WH, Schneider JR, Ferrucci L, Celic L, Taylor LM, Vonesh E, Martin GJ, Clark E.

JAMA. 2004 Jul 28;292(4):453-61.

PMID:
15280343
35.

Hemoglobin levels and erythropoietin doses in hemodialysis and peritoneal dialysis patients in the United States.

Snyder JJ, Foley RN, Gilbertson DT, Vonesh EF, Collins AJ.

J Am Soc Nephrol. 2004 Jan;15(1):174-9.

36.

Eating ability in head and neck cancer patients after treatment with chemoradiation: a 12-month follow-up study accounting for dropout.

Rademaker AW, Vonesh EF, Logemann JA, Pauloski BR, Liu D, Lazarus CL, Newman LA, May AH, MacCracken E, Gaziano J, Stachowiak L.

Head Neck. 2003 Dec;25(12):1034-41.

PMID:
14648862
37.

Survival of functionally anuric patients on automated peritoneal dialysis: the European APD Outcome Study.

Brown EA, Davies SJ, Rutherford P, Meeus F, Borras M, Riegel W, Divino Filho JC, Vonesh E, van Bree M; EAPOS Group.

J Am Soc Nephrol. 2003 Nov;14(11):2948-57.

38.

Body size and outcomes on peritoneal dialysis in the United States.

Snyder JJ, Foley RN, Gilbertson DT, Vonesh EF, Collins AJ.

Kidney Int. 2003 Nov;64(5):1838-44.

39.

Implications of the ADEMEX trial.

Mujais S, Vonesh E, Abu-Alfa A.

Contrib Nephrol. 2003;(140):131-41. Review. No abstract available.

PMID:
12800353
40.

Profiling of peritoneal ultrafiltration.

Mujais S, Vonesh E.

Kidney Int Suppl. 2002 Oct;(81):S17-22. Review. No abstract available.

PMID:
12230478
41.

Effects of increased peritoneal clearances on mortality rates in peritoneal dialysis: ADEMEX, a prospective, randomized, controlled trial.

Paniagua R, Amato D, Vonesh E, Correa-Rotter R, Ramos A, Moran J, Mujais S; Mexican Nephrology Collaborative Study Group.

J Am Soc Nephrol. 2002 May;13(5):1307-20.

42.

The effect of technique failure on outcome in black patients on continuous ambulatory peritoneal dialysis.

Kim GC, Vonesh EF, Korbet SM.

Perit Dial Int. 2002 Jan-Feb;22(1):53-9.

PMID:
11929145
43.

Validation of PD Adequest 2.0 for pediatric dialysis patients.

Warady BA, Watkins SL, Fivush BA, Andreoli SP, Salusky I, Kohaut EC, Vonesh EF.

Pediatr Nephrol. 2001 Mar;16(3):205-11.

PMID:
11322365
44.

Effect of cause and time of dropout on the residual GFR: a comparative analysis of the decline of GFR on dialysis.

Misra M, Vonesh E, Van Stone JC, Moore HL, Prowant B, Nolph KD.

Kidney Int. 2001 Feb;59(2):754-63.

45.

Patient survival among incident peritoneal dialysis and hemodialysis patients in an urban setting.

Tanna MM, Vonesh EF, Korbet SM.

Am J Kidney Dis. 2000 Dec;36(6):1175-82.

PMID:
11096042
46.
47.

Preservation of glomerular filtration rate on dialysis when adjusted for patient dropout.

Misra M, Vonesh E, Churchill DN, Moore HL, Van Stone JC, Nolph KD.

Kidney Int. 2000 Feb;57(2):691-6.

48.

A multinational clinical validation study of PD ADEQUEST 2.0. PD ADEQUEST International Study Group.

Vonesh EF, Story KO, O'Neill WT.

Perit Dial Int. 1999 Nov-Dec;19(6):556-71.

PMID:
10641777
49.

Membrane transport models and computerized kinetic modeling applied to automated peritoneal dialysis.

Vonesh EF.

Contrib Nephrol. 1999;129:15-34. Review. No abstract available.

PMID:
10590860
50.

Racial differences in survival in an urban peritoneal dialysis program.

Korbet SM, Shih D, Cline KN, Vonesh EF.

Am J Kidney Dis. 1999 Oct;34(4):713-20.

PMID:
10516354

Supplemental Content

Loading ...
Support Center